Combination therapy of cancer with AZD2171 and gemcitabine

Details for Australian Patent Application No. 2006264620 (hide)

Owner AstraZeneca AB

Inventors Wedge, Stephen Robert

Agent Davies Collison Cave

Pub. Number AU-B-2006264620

PCT Pub. Number WO2007/003933

Priority 0513778.1 06.07.05 GB; 0514347.4 13.07.05 GB

Filing date 3 July 2006

Wipo publication date 11 January 2007

Acceptance publication date 22 October 2009

International Classifications

A61K 31/7068 (2006.01)

A61K 31/517 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2007/003933 Priority application(s): WO2007/003933

22 October 2009 Application Accepted

  Published as AU-B-2006264620

18 February 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006264625-Improved methods of detecting viabilityassociated molecules

2006264612-Gas powered fastening apparatus